Efficacy of chloroquine plus low-dose primaquine and pyronaridine-artesunate plus low-dose primaquine against Plasmodium vivax malaria in adults and transmission to mosquitoes in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trial.

Bezabih MK, Sisay S, Behaksera SW, Ramjith J, Teka H, Girma S, Shimelash A, Ejigu LA, Kassa FA, Hailegiorgis B, Tadesse M, Misganaw T, Gizat A, Gashaw A, Habtamu G, Legesse NS, Hundera NL, Milki DW, Abdo M, Chali W, Tongren JE, Hwang J, Bousema T, Tadesse FG.

Open source

DOI: 10.1016/j.lanmic.2025.101342
Published: 2026-06-08
Container: Lancet Microbe
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.lanmic.2025.101342,
  title = {Efficacy of chloroquine plus low-dose primaquine and pyronaridine-artesunate plus low-dose primaquine against Plasmodium vivax malaria in adults and transmission to mosquitoes in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trial.},
  author = {Bezabih MK and  Sisay S and  Behaksera SW and  Ramjith J and  Teka H and  Girma S and  Shimelash A and  Ejigu LA and  Kassa FA and  Hailegiorgis B and  Tadesse M and  Misganaw T and  Gizat A and  Gashaw A and  Habtamu G and  Legesse NS and  Hundera NL and  Milki DW and  Abdo M and  Chali W and  Tongren JE and  Hwang J and  Bousema T and  Tadesse FG.},
  year = {2026},
  journal = {Lancet Microbe},
  doi = {10.1016/j.lanmic.2025.101342},
  url = {https://doi.org/10.1016/j.lanmic.2025.101342}
}

RIS

TY  - JOUR
TI  - Efficacy of chloroquine plus low-dose primaquine and pyronaridine-artesunate plus low-dose primaquine against Plasmodium vivax malaria in adults and transmission to mosquitoes in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trial.
AU  - Bezabih MK
AU  -  Sisay S
AU  -  Behaksera SW
AU  -  Ramjith J
AU  -  Teka H
AU  -  Girma S
AU  -  Shimelash A
AU  -  Ejigu LA
AU  -  Kassa FA
AU  -  Hailegiorgis B
AU  -  Tadesse M
AU  -  Misganaw T
AU  -  Gizat A
AU  -  Gashaw A
AU  -  Habtamu G
AU  -  Legesse NS
AU  -  Hundera NL
AU  -  Milki DW
AU  -  Abdo M
AU  -  Chali W
AU  -  Tongren JE
AU  -  Hwang J
AU  -  Bousema T
AU  -  Tadesse FG.
PY  - 2026
JO  - Lancet Microbe
DO  - 10.1016/j.lanmic.2025.101342
UR  - https://doi.org/10.1016/j.lanmic.2025.101342
ER  -

APA

MK, B., S, S., SW, B., J, R., H, T., S, G., A, S., LA, E., FA, K., B, H., M, T., T, M., A, G., A, G., G, H., NS, L., NL, H., DW, M., M, A., W, C., JE, T., J, H., T, B., & FG., T. (2026). Efficacy of chloroquine plus low-dose primaquine and pyronaridine-artesunate plus low-dose primaquine against Plasmodium vivax malaria in adults and transmission to mosquitoes in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trial.. Lancet Microbe. https://doi.org/10.1016/j.lanmic.2025.101342

Source records

europe-pmc · retrieved 2026-09-25T20:20:57.849Z